Catalyst Pharmaceuticals Inc. (CPRX)

Catalyst Pharmaceuticals Inc. (CPRX $19.86)
- $19.86 P/E (TTM): 12.65X Cap: $2.43B
- View CPRX Profile
- View Questions on CPRX

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Catalyst Pharmaceuticals Inc. (CPRX $19.86)
- $19.86 P/E (TTM): 12.65X Cap: $2.43B
- View CPRX Profile
- View Questions on CPRX

Q: Hi 5i Team,
Pls comment on Catalyst Pharmaceuticals quarter earning and this company going forward.
Thanks .

Read Answer Asked by Pui on August 07, 2025

Gilead Sciences Inc. (GILD $119.41)
- $119.41 P/E (TTM): 25.09X Cap: $148.16B
- View GILD Profile
- View Questions on GILD
Intuitive Surgical Inc. (ISRG $470.08)
- $470.08 P/E (TTM): 65.47X Cap: $168.51B
- View ISRG Profile
- View Questions on ISRG
AbbVie Inc. (ABBV $198.05)
- $198.05 P/E (TTM): 84.64X Cap: $349.86B
- View ABBV Profile
- View Questions on ABBV
Johnson & Johnson (JNJ $173.33)
- $173.33 P/E (TTM): 18.54X Cap: $417.43B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $625.65)
- $625.65 P/E (TTM): 50.91X Cap: $592.15B
- View LLY Profile
- View Questions on LLY
Medtronic plc. (MDT $92.88)
- $92.88 P/E (TTM): 25.73X Cap: $119B
- View MDT Profile
- View Questions on MDT
Stryker Corporation (SYK $377.58)
- $377.58 P/E (TTM): 50.01X Cap: $144.35B
- View SYK Profile
- View Questions on SYK
Thermo Fisher Scientific Inc (TMO $460.72)
- $460.72 P/E (TTM): 26.65X Cap: $173.97B
- View TMO Profile
- View Questions on TMO
Health Care Select Sector SPDR (XLV $130.16)
- $130.16 P/E (TTM): 65.74X Cap: $31.97B
- View XLV Profile
- View Questions on XLV
iShares U.S. Medical Devices ETF (IHI $61.32)
- $61.32 P/E (TTM): 105.73X Cap: $4.34B
- View IHI Profile
- View Questions on IHI
Sabra Health Care REIT Inc. (SBRA $18.72)
- $18.72 P/E (TTM): 31.52X Cap: $4.48B
- View SBRA Profile
- View Questions on SBRA
Healthcare Realty Trust Incorporated (HR $16.67)
- $16.67 Cap: $5.86B
- View HR Profile
- View Questions on HR
iShares U.S. Pharmaceuticals ETF (IHE $66.06)
- $66.06 P/E (TTM): 57.72X Cap: $541M
- View IHE Profile
- View Questions on IHE
Catalyst Pharmaceuticals Inc. (CPRX $19.86)
- $19.86 P/E (TTM): 12.65X Cap: $2.43B
- View CPRX Profile
- View Questions on CPRX

Q: There was an article in the Globe and Mail today by David Rosenberg about the aging population and he suggested health care related investments such as health care REITS, pharma, devices, and services. What do you think of this idea and can you give me a few recommendations in canada and the US for each of the 4 categories (health reits, pharma, devices, sefrvices)? A mix of ETFS and individual stocks would be great.

Read Answer Asked by Carla on July 08, 2025

Catalyst Pharmaceuticals Inc. (CPRX $19.86)
- $19.86 P/E (TTM): 12.65X Cap: $2.43B
- View CPRX Profile
- View Questions on CPRX

Q: Its valuation certainly calls for a buy and its forward PE. Do you still view this stock as a slow long term compounder in this field?

Is there anything I’m missing or could be a risk?
Any additional insight on this company or a preferred leader in its sector would be great.

Thank you.

Read Answer Asked by Adam on July 02, 2025